Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125388431 | 12538843 | 1 | I | 20160701 | 20160708 | 20160708 | PER | US-ASTRAZENECA-2016SE73049 | ASTRAZENECA | 0.00 | M | Y | 0.00000 | 20160708 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125388431 | 12538843 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | 21153 | 40 | MG | CAPSULE | QD | ||||||
| 125388431 | 12538843 | 2 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125388431 | 12538843 | 1 | Gastrooesophageal reflux disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125388431 | 12538843 | Abdominal pain upper | |
| 125388431 | 12538843 | Chest pain | |
| 125388431 | 12538843 | Feeling abnormal | |
| 125388431 | 12538843 | Mouth ulceration | |
| 125388431 | 12538843 | Nausea | |
| 125388431 | 12538843 | Oropharyngeal pain | |
| 125388431 | 12538843 | Pain | |
| 125388431 | 12538843 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125388431 | 12538843 | 1 | 201606 | 0 | ||
| 125388431 | 12538843 | 2 | 201606 | 0 |